Until now only estrogen receptor (ESR1) and progesterone receptor (PGR) have been routinely assessed as hormone receptors in human breast cancer due to their prognostic and predictive value in human mammary carcinoma therapy [1]. This evidence concerns the gene PGR and breast cancer.